Cytosorbents
CTSO
$0.97
Share price
11.69%
Change (1 day)
-70.94%
Change (1 year)
Categories
Market capitalization of Cytosorbents (CTSO)
Market cap: $52.54 Million
As of May 2024 Cytosorbents has a market cap of $52.54 Million. This makes Cytosorbents the world's 7763th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cytosorbents from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $52.54 M | -9.26% |
| 2023 | $57.91 M | -14.38% |
| 2022 | $67.63 M | -62.87% |
| 2021 | $0.18 B | -47.12% |
| 2020 | $0.34 B | 174.33% |
| 2019 | $0.12 B | -51.09% |
| 2018 | $0.25 B | 37.66% |
| 2017 | $0.18 B | 34.36% |
| 2016 | $0.13 B | -1.88% |
| 2015 | $0.14 B | -38.99% |
| 2014 | $0.23 B | 638.12% |
| 2013 | $31.41 M | 12.41% |
| 2012 | $27.94 M | -1.54% |
| 2011 | $28.38 M | 65.04% |
| 2010 | $17.19 M | 36.37% |
| 2009 | $12.61 M | 523.98% |
| 2008 | $2.02 M |
End of Day market cap according to different sources
On May 19th, 2024 the market cap of Cytosorbents was reported to be:
$52.54 Million
$52.54 Million
$52.54 Million
$52.54 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $109.74 B | 208,759.12% | 🇺🇸 USA |
 Hologic HOLX | $17.50 B | 33,218.71% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $1.48 B | 2,733.34% | 🇺🇸 USA |